Sevil Bavbek

Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim et al. · Journal of Clinical Oncology · 2014 · 426 citations · Full text

Skull Base Plasmacytoma in a Patient with Light Chain Myeloma

Zeki Üstüner, Mert Başaran, Serra Sencer et al. · Skull base · 2004 · 44 citations · Full text

Hematological Malignancy, Neuro-oncology, Skull Base Plasmacytoma +8

CD44 variant exons in leukemia and lymphoma

Elif Akýsýk, Sevil Bavbek, Nejat Dalay · Pathology & Oncology Research · 2002 · 36 citations

Lymphoid Neoplasia, Malignant Blood Disorder, Pathology +5

Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer

Ethem Nezih Oral, Sevil Bavbek, Ahmet Kizir et al. · Lung Cancer · 1999 · 31 citations

Medicine, Cancer Management, Phase Ii Study +7

Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib.

Fatma Şen, Mevhibe Başaran, Meltem Ekenel et al. · PubMed · 2014 · 22 citations